Advice To Community Oncologists Treating Patients With CRC
Al B. Benson III, MD, FACP, FASCO, professor of medicine at Northwestern University, shares advice to community oncologists treating patients with colorectal cancer. He emphasizes looking carefully at different patient characteristics before making treatment decisions.
Al B. Benson III, MD, FACP, FASCO, professor of medicine at Northwestern University, shares advice to community oncologists treating patients with colorectal cancer (CRC). He emphasizes looking carefully at different patient characteristics before making treatment decisions.
Patient preference, patient characteristics, molecular characteristics, and tumor characteristics are critical in defining an optimal sequential treatment approach for patients with CRC, Benson says. He adds that there is growing evidence in integrating these characteristics with the sequential approach in order to give the most beneficial treatment to each individual patient.
Retrospective Data Demonstrates Efficacy of Regorafenib in mCRC
April 16th 2024During a Case-Based Roundtable® event, Madappa Kundranda, MD, PhD, discussed recent retrospective studies that compared outcomes between the available treatment options in patients with relapsed/refractory advanced colorectal cancer in the first article of a 2-part series.
Read More
